Search

everythinglearnresearchcommunity

for

Search:↓

Prostasin has two roles in skin: one for normal skin development without needing activation, and another for proper hair growth that requires activation.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Finasteride causes temporary cell death in BPH tissues.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Certain drugs that block specific enzymes can help treat prostate diseases.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Purple corn extract may help reduce prostate enlargement and inflammation.

Pterostilbene significantly reduces prostate enlargement and has strong antioxidant effects.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

A mix of Panax ginseng and bee-pollen may help prevent prostate enlargement in rats.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

New research on prostamide F2α has led to treatments for glaucoma and eyelash growth and may have more medical uses.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Methyl vanillate spray increases hair count and hair mass in women with hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride effectively blocks enzyme causing male pattern baldness.